For: |
Sereni G, Azzolini F, Camellini L, Formisano D, Decembrino F, Iori V, Tioli C, Cavina M, Di Mario F, Bedogni G, Sassatelli R. Efficacy of a therapeutic strategy for eradication of |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i33/4542.htm |
Number | Citing Articles |
1 |
Vincenzo De Francesco, Angelo Zullo, Luigi Gatta, Raffaele Manta, Matteo Pavoni, Ilaria Maria Saracino, Giulia Fiorini, Dino Vaira. Rescue Therapies for H. pylori Infection in Italy. Antibiotics 2021; 10(5): 525 doi: 10.3390/antibiotics10050525
|
2 |
V De Francesco, A Zullo, R Manta, M Pavoni, IM Saracino, G Fiorini, F Giostra, G Monti, D Vaira. First-line therapies for H. pylori infection in Italy: a pooled-data analysis. Acta Gastro Enterologica Belgica 2022; 85(2): 295 doi: 10.51821/85.2.9680
|
3 |
Ignasi Puig, Sheila López-Góngora, Xavier Calvet, Albert Villoria, Mireia Baylina, Jordi Sanchez-Delgado, David Suarez, Victor García-Hernando, Javier P. Gisbert. Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infection. Therapeutic Advances in Gastroenterology 2016; 9(4): 437 doi: 10.1177/1756283X15621229
|
4 |
Constantin Hays, Thibault Delerue, Dominique Lamarque, Christophe Burucoa, Ghislaine Collobert, Annick Billöet, Nicolas Kalach, Josette Raymond. Molecular diagnosis of Helicobacter pylori infection in gastric biopsies: Evaluation of the Amplidiag®H. pylori + ClariR assay. Helicobacter 2019; 24(2) doi: 10.1111/hel.12560
|
5 |
Ignasi Puig, Jesús M. González-Santiago, Javier Molina-Infante, Jesús Barrio, Maria Teresa Herranz, Alicia Algaba, Manuel Castro, Javier P. Gisbert, Xavier Calvet. Fourteen-day high-dose esomeprazole, amoxicillin and metronidazole as third-line treatment forHelicobacter pyloriinfection. International Journal of Clinical Practice 2017; 71(9): e13004 doi: 10.1111/ijcp.13004
|
6 |
Ignasi Puig, Mireia Baylina, Jordi Sánchez-Delgado, Sheila López-Gongora, David Suarez, Pilar García-Iglesias, Neus Muñoz, Javier P. Gisbert, Cristina Dacoll, Henry Cohen, Xavier Calvet. Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole forHelicobacter pylorifirst-line treatment. Journal of Antimicrobial Chemotherapy 2016; 71(10): 2740 doi: 10.1093/jac/dkw220
|